Clinical Trial Update: Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating switching from TDF-based ART regimens to B/F/TAF in virally suppressed adults with HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• B/F/TAF (emtricitabine/tenofovir alafenamide/cobicistat-darunavir)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: HIV-1-infection | Phase 4 | Status: UNKNOWN